Back to VANGUARD GROUP INC VANGUARD GROUP INC

ARQTARQT
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in ARCUTIS BIOTHERAPEUTICS INC

VANGUARD GROUP INC holds 7.3M shares of ARQT (ARCUTIS BIOTHERAPEUTICS INC), worth $210.7M as of 2025-Q4. The position was increased (+1.5% shares). ARQT represents 0.0% of VANGUARD GROUP INC's portfolio.

Current Value

$210.7M

Current Shares

7.3M

Total Value Change

+$145.9M

Total Shares Change

+291,301

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
7.3M
+1.5%
$210.7M0.0%$28.08
31
2025-Q3
Increased
7.1M
+1.4%
$134.7M0.0%$18.62
31
2025-Q2
Increased
7M
+3.4%
$98.8M0.0%$13.74
31
2025-Q1
Increased
6.8M
+5.9%
$106.6M0.0%$15.73
32
2024-Q4
Decreased
6.4M
-7.5%
$89.7M0.0%$14.20
0
2024-Q3
New
7M
-
$64.8M0.0%$9.36
41

Other major holders of ARQT: BlackRock, Inc., JENNISON ASSOCIATES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used